Literature
Chen, D.-S., Lai, M.-Y., Sung, J.-L. Delta-agent infection in patients with chronic liver disease and hepatocellular carcinoma — an infrequent finding in Taiwan. Hepatology 4 (1984) 502–503.
Kew, M. C., Dusheiko, G. M., Hadziyannis, S. J., Patterson, A. Does delta infection play a part in the pathogenesis of hepatitis B virus related primary hepatocellular carcinoma? Br. Med. J. 288 (1984) 1727.
Govindarajan, S., Hevia, F. J., Peters, R. L. Prevalence of delta antigen/antibody in B-viral associated hepatocellular carcinoma. Cancer 53 (1984) 1692–1694.
Craxi, A., Raimondo, G., Giannuoli G., Longo, G., Caltagirone, M., Aragona, M., Squadrito, G., Pagliaro, L.: Delta agent and hepatocellular carcinoma. In:Verme, G., Bonino, F., Rizetto, M. (eds.): Delta infection and virus hepatitis. Progress in Clinical and Biological Research, Vol. 143, New York 1984, pp. 231–234.
Arya, S. C., Ashraf, S. J., Parande, C. M., El-Sayed, M., Sahay, R., Ageel, A. R., Tobeiqi, M. S. Hepatitis B virus in Gizan, Saudi Arabia. J. Med. Virol. 17 (1985) 267–274.
Nakamura, R. M., Molden, D. P. Hepatoma screening in hepatitis B carriers. J. Am. Med. Assoc. 252 (1984) 2967–2968.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ashraf, S.J., Arya, S.C., Sahay, R. et al. Anti-delta antibody in primary hepatocellular carcinoma patients in the gizan area of saudi arabia. Infection 14, 250–251 (1986). https://doi.org/10.1007/BF01644273
Issue Date:
DOI: https://doi.org/10.1007/BF01644273